AI-generated summary
Thirty elderly women took part in a crossover, double-blinded, placebo-controlled trial testing 808 nm photobiomodulation before a muscle fatigue protocol. The authors report that the treatment was associated with a higher electromyographic fatigue index and lower blood lactate than placebo, but no improvement in muscle performance on the isokinetic dynamometer.
- Participants
- 30
- Who or what was studied
- Elderly women
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract does not describe the sample's age range or the statistical details beyond p-values, so the clinical significance of the reported differences is unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Power
- 100 mW
- Total energy
- 7 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Placebo-controlled, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.